Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (411-420 of 632) with videos related to

Pageof 64
Sort By:
Journal of Viral Hepatitis|October 14, 2018
Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral treatmentViola Knop, Wolf P Hofmann, Peter Buggisch, et al.
Cellular and Molecular Life Sciences : CMLS|January 9, 2026
Modeling the dynamics of hepatic metabolism: the predominance of 12-hour rhythmicity in metabolic adaptationMadlen Matz-Soja, Christiane Körner, Fritzi Ott, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 25, 2015
Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null respondersBalazs Fülöp, Michael Biermer, Markus Cornberg, et al.
Plos One|November 17, 2011
The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosisHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
Journal of Hepatology|July 17, 2022
Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLFCornelius Engelmann, Abeba Habtesion, Mohsin Hassan, et al.
Cardiovascular and Interventional Radiology|October 30, 2021
Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancersRhea Veelken, Bettina Maiwald, Steffen Strocka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 21, 2019
Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitisLena Maria Greverath, Elise Leicht, Nina Wald de Chamorro, et al.
Zeitschrift Fur Gastroenterologie|July 13, 2021
Markus Cornberg, Lisa Sandmann, Ulrike Protzer, et al.
The New England Journal of Medicine|November 30, 2007
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis CJohn G McHutchison, Geoffrey Dusheiko, Mitchell L Shiffman, et al.
Plos One|December 4, 2018
Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patientsMonika Rau, Johannes Schmitt, Thomas Berg, et al.
Pageof 64

Showing results (411-420 of 632) with videos related to

Sort By:
Pageof 64
Journal of Viral Hepatitis|October 14, 2018
Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral treatmentViola Knop, Wolf P Hofmann, Peter Buggisch, et al.
Cellular and Molecular Life Sciences : CMLS|January 9, 2026
Modeling the dynamics of hepatic metabolism: the predominance of 12-hour rhythmicity in metabolic adaptationMadlen Matz-Soja, Christiane Körner, Fritzi Ott, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 25, 2015
Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null respondersBalazs Fülöp, Michael Biermer, Markus Cornberg, et al.
Plos One|November 17, 2011
The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosisHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
Journal of Hepatology|July 17, 2022
Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLFCornelius Engelmann, Abeba Habtesion, Mohsin Hassan, et al.
Cardiovascular and Interventional Radiology|October 30, 2021
Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancersRhea Veelken, Bettina Maiwald, Steffen Strocka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 21, 2019
Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitisLena Maria Greverath, Elise Leicht, Nina Wald de Chamorro, et al.
Zeitschrift Fur Gastroenterologie|July 13, 2021
Markus Cornberg, Lisa Sandmann, Ulrike Protzer, et al.
The New England Journal of Medicine|November 30, 2007
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis CJohn G McHutchison, Geoffrey Dusheiko, Mitchell L Shiffman, et al.
Plos One|December 4, 2018
Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patientsMonika Rau, Johannes Schmitt, Thomas Berg, et al.
Pageof 64